|
|
|
Volumn 19, Issue 6 Suppl, 2004, Pages
|
|
Type 2 diabetes and chronic systolic heart failure: clinical implications.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANTIDIABETIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARDIOTONIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
CHRONIC DISEASE;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
DISEASE COURSE;
DRUG COMBINATION;
HUMAN;
INSULIN RESISTANCE;
METABOLISM;
MORBIDITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
RISK FACTOR;
RISK REDUCTION;
SYSTOLE;
ADRENERGIC BETA-ANTAGONISTS;
ALDOSTERONE ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CARDIOTONIC AGENTS;
CHRONIC DISEASE;
DIABETES COMPLICATIONS;
DIABETES MELLITUS, TYPE 2;
DISEASE PROGRESSION;
DIURETICS;
DRUG THERAPY, COMBINATION;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN RESISTANCE;
MORBIDITY;
RISK FACTORS;
RISK REDUCTION BEHAVIOR;
SYSTOLE;
|
|
EID: 16644394975
PISSN: 08894655
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (72)
|
